- Home
- THAR vs SBET Comparison
THAR vs SBET Comparison
Compare THAR & SBET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THAR
- SBET
- Stock Information
- Founded
- THAR 2017
- SBET 1995
- Country
- THAR United States
- SBET United States
- Employees
- THAR N/A
- SBET N/A
- Industry
- THAR Biotechnology: Pharmaceutical Preparations
- SBET Computer Software: Prepackaged Software
- Sector
- THAR Health Care
- SBET Technology
- Exchange
- THAR Nasdaq
- SBET Nasdaq
- Market Cap
- THAR 2.8M
- SBET 2.4M
- IPO Year
- THAR 2022
- SBET 1997
- Fundamental
- Price
- THAR $2.13
- SBET $0.78
- Analyst Decision
- THAR
- SBET
- Analyst Count
- THAR 0
- SBET 0
- Target Price
- THAR N/A
- SBET N/A
- AVG Volume (30 Days)
- THAR 232.7K
- SBET 1.6M
- Earning Date
- THAR 11-07-2024
- SBET 11-15-2024
- Dividend Yield
- THAR N/A
- SBET N/A
- EPS Growth
- THAR N/A
- SBET N/A
- EPS
- THAR N/A
- SBET 1.81
- Revenue
- THAR N/A
- SBET $3,866,015.00
- Revenue This Year
- THAR N/A
- SBET N/A
- Revenue Next Year
- THAR N/A
- SBET N/A
- P/E Ratio
- THAR N/A
- SBET $0.47
- Revenue Growth
- THAR N/A
- SBET 56.18
- 52 Week Low
- THAR $1.84
- SBET $0.41
- 52 Week High
- THAR $8.55
- SBET $2.18
- Technical
- Relative Strength Index (RSI)
- THAR 46.63
- SBET 56.69
- Support Level
- THAR $2.09
- SBET $0.71
- Resistance Level
- THAR $2.27
- SBET $0.85
- Average True Range (ATR)
- THAR 0.17
- SBET 0.15
- MACD
- THAR -0.00
- SBET 0.01
- Stochastic Oscillator
- THAR 34.04
- SBET 56.34
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset, known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
About SBET SharpLink Gaming Ltd.
SharpLink Gaming Inc is a online technology company that connects sports fans, leagues and sports websites to relevant and timely sports betting content. The company owns a performance marketing platform through which the Company owns and operates state-specific web domains designed to attract, acquire, and drive local sports betting and casino traffic directly to its sportsbook and casino partners which are licensed to operate in each respective state. The Company has two operating segments: Affiliate Marketing Services-United States and Affiliate Marketing Services-International. The company generates the majority of the revenue earned from the Affiliate Marketing Services-International segment.